Curcumin Ameliorates Ovalbumin-Induced Atopic Dermatitis and Blocks the Progression of Atopic March in Mice

  • 153 Accesses

  • 2 Citations


Curcumin, extracted from the roots of Curcuma longa, has been used as an anti-inflammatory agent since the time of Ayurveda. The present work was designed to evaluate the potential of curcumin in amelioration of ovalbumin (OVA) induced AD in mice. Female BALB/c mice were subjected to skin OVA-patch application for a period of 1 week followed by resting period of 2 weeks, and the same protocol was repeated thrice. Curcumin was administered daily at dose of 20 mg/kg (i.p.) for 7 consecutive days during last sensitization phase. The phytochemical ameliorated the OVA-induced skin pathology as evident by normalization of epidermal thickness and suppressed infiltration of inflammatory cells in dermal region. The expression of Th2 promoting cytokines (TSLP/IL-33) and Th2 cytokines (IL-4/IL-5/IL-13/IL-31) was suppressed markedly along with reduced STAT-6 phosphorylation and GATA-3 expression. Curcumin administration also restored the redox balance and phosphorylation status of P65-NF-κB. Additionally, the epicutaneously sensitized mice challenged with aerosolized OVA developed asthmatic features which were effectively thwarted back upon curcumin treatment as reflected by data on total/differential cells in BALF and mRNA expression of Th2 cytokines in lungs. Overall, our findings demonstrate that curcumin treatment blunts the development of AD as well as associated atopic march in experimental mice.

This is a preview of subscription content, log in to check access.

Access options

Buy single article

Instant unlimited access to the full article PDF.

US$ 39.95

Price includes VAT for USA

Subscribe to journal

Immediate online access to all issues from 2019. Subscription will auto renew annually.

US$ 199

This is the net price. Taxes to be calculated in checkout.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6


  1. 1.

    Leung, D.Y. 1995. Atopic dermatitis: the skin as a window into the pathogenesis of chronic allergic diseases. The Journal of Allergy and Clinical Immunology 96: 302–318.

  2. 2.

    Zheng, T., J. Yu, M.H. Oh, and Z. Zhu. 2011. The atopic march: progression from atopic dermatitis to allergic rhinitis and asthma. Allergy, Asthma & Immunology Research 3: 67–73.

  3. 3.

    Brunner, P.M., E. Guttman-Yassky, and D.Y. Leung. 2017. The immunology of atopic dermatitis and its reversibility with broad-spectrum and targeted therapies. The Journal of Allergy and Clinical Immunology 139: S65–s76.

  4. 4.

    Salazar-Espinosa, J.F. 2014. The atopic march. A literature review. International Journal of Medical Students 2: 119–123.

  5. 5.

    Leung, D.Y., and T. Bieber. 2003. Atopic dermatitis. Lancet 361: 151–160.

  6. 6.

    Allakhverdi, Z., D.E. Smith, M.R. Comeau, and G. Delespesse. 2007. Cutting edge: The ST2 ligand IL-33 potently activates and drives maturation of human mast cells. Journal of Immunology 179: 2051–2054.

  7. 7.

    Wilson, S.R., The L, L.M. Batia, K. Beattie, G.E. Katibah, S.P. McClain, et al. 2013. The epithelial cell-derived atopic dermatitis cytokine TSLP activates neurons to induce itch. Cell 155: 285–295.

  8. 8.

    Jin, H., R. He, M. Oyoshi, and R.S. Geha. 2009. Animal models of atopic dermatitis. The Journal of Investigative Dermatology 129: 31–40.

  9. 9.

    Peng, W., and N. Novak. 2015. Pathogenesis of atopic dermatitis. Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology 45: 566–574.

  10. 10.

    Furue, M., T. Chiba, G. Tsuji, D. Ulzii, M. Kido-Nakahara, T. Nakahara, and T. Kadono. 2017. Atopic dermatitis: immune deviation, barrier dysfunction, IgE autoreactivity and new therapies. Allergology International 66: 398–403.

  11. 11.

    Spergel, J.M., and A.S. Paller. 2003. Atopic dermatitis and the atopic march. The Journal of Allergy and Clinical Immunology 112: S118–S127.

  12. 12.

    Tran, M.M., D.L. Lefebvre, C. Dharma, D. Dai, W.Y.W. Lou, P. Subbarao, et al. 2017. Predicting the atopic march: results from the Canadian Healthy Infant Longitudinal Development Study. The Journal of Allergy and Clinical Immunology 141: 601–607 e8.

  13. 13.

    Hill, D.A., and J.M. Spergel. 2018. The atopic march: critical evidence and clinical relevance. Annals of Allergy, Asthma & Immunology 120: 131–137.

  14. 14.

    Spergel, J.M., E. Mizoguchi, J.P. Brewer, T.R. Martin, A.K. Bhan, and R.S. Geha. 1998. Epicutaneous sensitization with protein antigen induces localized allergic dermatitis and hyperresponsiveness to methacholine after single exposure to aerosolized antigen in mice. The Journal of Clinical Investigation 101: 1614–1622.

  15. 15.

    Silverberg, J.I., D.B. Nelson, and G. Yosipovitch. 2016. Addressing treatment challenges in atopic dermatitis with novel topical therapies. The Journal of Dermatological Treatment 27: 568–576.

  16. 16.

    Nygaard, U., M. Deleuran, and C. Vestergaard. 2017. Emerging Treatment Options in Atopic Dermatitis: Topical Therapies. Dermatology 233: 333–343.

  17. 17.

    Huang, A., C. Cho, D.Y.M. Leung, and K. Brar. 2018. Atopic dermatitis: early treatment in children. Current Treatment Options in Allergy 4: 355–369.

  18. 18.

    Thakare, V.N., M.M. Osama, and S.R. Naik. 2013. Therapeutic potential of curcumin in experimentally induced allergic rhinitis in guinea pigs. International Immunopharmacology 17: 18–25.

  19. 19.

    Ammon, H.P., and M.A. Wahl. 1991. Pharmacology of Curcuma longa. Planta Medica 57: 1–7.

  20. 20.

    Karaman, M., F. Firinci, S. Cilaker, P. Uysal, K. Tugyan, O. Yilmaz, N. Uzuner, and O. Karaman. 2012. Anti-inflammatory effects of curcumin in a murine model of chronic asthma. Allergologia et Immunopathologia 40: 210–214.

  21. 21.

    Oh, S.W., J.Y. Cha, J.E. Jung, B.C. Chang, H.J. Kwon, B.R. Lee, et al. 2011. Curcumin attenuates allergic airway inflammation and hyper-responsiveness in mice through NF-kappaB inhibition. Journal of Ethnopharmacology 136: 414–421.

  22. 22.

    Sakai, H., K. Sato, F. Sato, Y. Kai, K. Mandokoro, K. Matsumoto, S. Kato, T. Yumoto, M. Narita, and Y. Chiba. 2017. Curcumin inhibits epigen and amphiregulin upregulated by 2,4,6-trinitrochlorobenzene associated with attenuation of skin swelling. Inflammation Research 66: 663–678.

  23. 23.

    Moon, P.D., H.J. Jeong, and H.M. Kim. 2013. Down-regulation of thymic stromal lymphopoietin by curcumin. Pharmacological Reports 65: 525–531.

  24. 24.

    Sethi, G.S., and A.S. Naura. 2018. Progressive increase in allergen concentration abrogates immune tolerance in ovalbumin-induced murine model of chronic asthma. International Immunopharmacology 60: 121–131.

  25. 25.

    Sahu, B., R. Sandhir, and A.S. Naura. 2018. Two hit induced acute lung injury impairs cognitive function in mice: a potential model to study cross talk between lung and brain. Brain, Behavior, and Immunity 73: 633–642.

  26. 26.

    Dharwal, V., and A.S. Naura. 2018. PARP-1 inhibition ameliorates elastase induced lung inflammation and emphysema in mice. Biochemical Pharmacology 150: 24–34.

  27. 27.

    Lowry, O.H., N.J. Rosebrough, A.L. Farr, and R.J. Randall. 1951. Protein measurement with the Folin phenol reagent. The Journal of Biological Chemistry 193: 265–275.

  28. 28.

    Wang, H., and J.A. Joseph. 1999. Quantifying cellular oxidative stress by dichlorofluorescein assay using microplate reader. Free Radical Biology & Medicine 27: 612–616.

  29. 29.

    Ohkawa, H., N. Ohishi, and K. Yagi. 1979. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Analytical Biochemistry 95: 351–358.

  30. 30.

    Levine, R.L., D. Garland, C.N. Oliver, A. Amici, I. Climent, A.G. Lenz, B.W. Ahn, S. Shaltiel, and E.R. Stadtman. 1990. Determination of carbonyl content in oxidatively modified proteins. Methods in Enzymology 186: 464–478.

  31. 31.

    Kono, Y. 1978. Generation of superoxide radical during autoxidation of hydroxylamine and an assay for superoxide dismutase. Archives of Biochemistry and Biophysics 186: 189–195.

  32. 32.

    Luck, H. 1965. Catalase. methods of enzymatic anaylsis, 885–894. New York: Academic Press.

  33. 33.

    Moron, M.S., J.W. Depierre, and B. Mannervik. 1979. Levels of glutathione, glutathione reductase and glutathione S-transferase activities in rat lung and liver. Biochimica et Biophysica Acta 582: 67–78.

  34. 34.

    Wang, G., T. Savinko, H. Wolff, M.C. Dieu-Nosjean, L. Kemeny, B. Homey, A.I. Lauerma, and H. Alenius. 2007. Repeated epicutaneous exposures to ovalbumin progressively induce atopic dermatitis-like skin lesions in mice. Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology 37: 151–161.

  35. 35.

    Wang, Y.H., and Y.J. Liu. 2009. Thymic stromal lymphopoietin, OX40-ligand, and interleukin-25 in allergic responses. Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology 39: 798–806.

  36. 36.

    Nygaard, U., M. Hvid, C. Johansen, M. Buchner, R. Folster-Holst, M. Deleuran, et al. 2016. TSLP, IL-31, IL-33 and sST2 are new biomarkers in endophenotypic profiling of adult and childhood atopic dermatitis. Journal of the European Academy of Dermatology and Venereology 30: 1930–1938.

  37. 37.

    Ji, H., and X.K. Li. 2016. Oxidative Stress in Atopic Dermatitis. Oxidative Medicine and Cellular Longevity 2016: 2721469.

  38. 38.

    Shakeri, F., M. Soukhtanloo, and M.H. Boskabady. 2017. The effect of hydro-ethanolic extract of Curcuma longa rhizome and curcumin on total and differential WBC and serum oxidant, antioxidant biomarkers in rat model of asthma. Iranian Journal of Basic Medical Sciences 20: 155–165.

  39. 39.

    Leung, D.Y. 1999. Pathogenesis of atopic dermatitis. The Journal of Allergy and Clinical Immunology 104: S99–S108.

  40. 40.

    Bantz, S.K., Z. Zhu, and T. Zheng. 2014. The Atopic March: Progression from Atopic Dermatitis to Allergic Rhinitis and Asthma. J Clin Cell Immunol 5: 202.

  41. 41.

    Lowe, A.J., D.Y.M. Leung, M.L.K. Tang, J.C. Su, and K.J. Allen. 2018. The skin as a target for prevention of the atopic march. Annals of Allergy, Asthma & Immunology 120: 145–151.

  42. 42.

    Shakeri, A., A.F.G. Cicero, Y. Panahi, M. Mohajeri, and A. Sahebkar. 2019. Curcumin: A naturally occurring autophagy modulator. Journal of Cellular Physiology 234: 5643–5654.

  43. 43.

    Zheng, T., and Z. Zhu. 2005. Lessons from murine models of atopic dermatitis. Current Allergy and Asthma Reports 5: 291–297.

  44. 44.

    Saluja, R., A. Zoltowska, M.E. Ketelaar, and G. Nilsson. 2016. IL-33 and Thymic Stromal Lymphopoietin in mast cell functions. European Journal of Pharmacology 778: 68–76.

  45. 45.

    Soumelis, V., P.A. Reche, H. Kanzler, W. Yuan, G. Edward, B. Homey, M. Gilliet, S. Ho, S. Antonenko, A. Lauerma, K. Smith, D. Gorman, S. Zurawski, J. Abrams, S. Menon, T. McClanahan, R. de Waal-Malefyt Rd, F. Bazan, R.A. Kastelein, and Y.J. Liu. 2002. Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP. Nature Immunology 3: 673–680.

  46. 46.

    Chen, B.L., Y.Q. Chen, B.H. Ma, S.F. Yu, L.Y. Li, Q.X. Zeng, Y.T. Zhou, Y.F. Wu, W.L. Liu, J.B. Wan, Y. Yang, and C.W. Li. 2018. Tetrahydrocurcumin, a major metabolite of curcumin, ameliorates allergic airway inflammation by attenuating Th2 response and suppressing the IL-4Ralpha-Jak1-STAT6 and Jagged1/Jagged2 -Notch1/Notch2 pathways in asthmatic mice. Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology 48: 1494–1508.

  47. 47.

    Chong, L., W. Zhang, Y. Nie, G. Yu, L. Liu, L. Lin, S. Wen, L. Zhu, and C. Li. 2014. Protective effect of curcumin on acute airway inflammation of allergic asthma in mice through Notch1-GATA3 signaling pathway. Inflammation 37: 1476–1485.

  48. 48.

    Brown, H.A., and J.M. Hanifin. 1990. Atopic dermatitis. Current Opinion in Immunology 2: 531–534.

  49. 49.

    Brandt, E.B., and U. Sivaprasad. 2011. Th2 Cytokines and Atopic Dermatitis. Journal of Clinical & Cellular Immunology 2: 110.

  50. 50.

    Yoshihisa, Y., T. Andoh, K. Matsunaga, M.U. Rehman, T. Maoka, and T. Shimizu. 2016. Efficacy of Astaxanthin for the Treatment of Atopic Dermatitis in a Murine Model. PLoS One 11: e0152288.

  51. 51.

    Addor, F.A.S. 2017. Antioxidants in dermatology. Anais Brasileiros de Dermatologia 92: 356–362.

  52. 52.

    Briganti, S., and M. Picardo. 2003. Antioxidant activity, lipid peroxidation and skin diseases. What's new. Journal of the European Academy of Dermatology and Venereology 17: 663–669.

  53. 53.

    Morgan, M.J., and Z.G. Liu. 2011. Crosstalk of reactive oxygen species and NF-kappaB signaling. Cell Research 21: 103–115.

  54. 54.

    Sahebkar, A., A.F.G. Cicero, L.E. Simental-Mendia, B.B. Aggarwal, and S.C. Gupta. 2016. Curcumin downregulates human tumor necrosis factor-alpha levels: A systematic review and meta-analysis ofrandomized controlled trials. Pharmacological Research 107: 234–242.

  55. 55.

    Buhrmann, C., A. Mobasheri, F. Busch, C. Aldinger, R. Stahlmann, A. Montaseri, and M. Shakibaei. 2011. Curcumin modulates nuclear factor kappaB (NF-kappaB)-mediated inflammation in human tenocytes in vitro: role of the phosphatidylinositol 3-kinase/Akt pathway. The Journal of Biological Chemistry 286: 28556–28566.

  56. 56.

    Mollazadeh, H., A.F.G. Cicero, C.N. Blesso, M. Pirro, M. Majeed, and A. Sahebkar. 2019. Immune modulation by curcumin: The role of interleukin-10. Critical Reviews in Food Science and Nutrition 59: 89–101.

  57. 57.

    Han, H., W. Xu, M.B. Headley, H.K. Jessup, K.S. Lee, M. Omori, M.R. Comeau, A. Marshak-Rothstein, and S.F. Ziegler. 2012. Thymic stromal lymphopoietin (TSLP)-mediated dermal inflammation aggravates experimental asthma. Mucosal Immunology 5: 342–351.

Download references

Author information

Conceptualization and design of experiments was done by Amarjit S Naura and Sukriti Sharma; Experiments were performed by Sukriti Sharma; Analysis of the data was done by Amarjit S Naura, Sukriti Sharma, and Gurupreet S Sethi. The draft of the manuscript was prepared by Sukriti Sharma and all authors reviewed and approved the final manuscript.

Correspondence to Amarjit S. Naura.

Ethics declarations

Conflict of Interest

The authors declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic Supplementary Material


(PDF 268 kb)

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Sharma, S., Sethi, G.S. & Naura, A.S. Curcumin Ameliorates Ovalbumin-Induced Atopic Dermatitis and Blocks the Progression of Atopic March in Mice. Inflammation (2019) doi:10.1007/s10753-019-01126-7

Download citation


  • atopic dermatitis
  • curcumin
  • atopic march
  • asthma
  • ovalbumin